News
And offering a fast-track to approve drugs the Trump administration views as a priority. Welcome to the new Food and Drug ...
All the figurative FDA trains are running on time, according to the agency’s leader Marty Makary, M.D. | “I'm proud to report ...
FDA Commissioner Marty Makary has told staff that Center for Biologics Evaluation and Research Director Vinay Prasad has been ...
The Food and Drug Administration says it will begin offering faster reviews to new medicines that align with Trump ...
1d
Pharmaceutical Technology on MSNFDA Commissioner envisions fewer delays, more clinical trial flexibility and AI useFDA Commissioner Dr Marty Makary tried to allay industry concerns about recent cuts and outlined his agenda for the future.
FDA Commissioner Marty Makary said that one of his key priorities is to modernize the agency by streamlining the drug review ...
The US Food and Drug Administration announced a new national priority voucher plan that aims to cut drug review times to one ...
1d
The Mirror US on MSNFDA to fast-track drug approvals for companies pushing ‘national priorities’ in major overhaulFood and Drug Administration Commissioner Marty Makary announced that the agency intends to fast-track reviews for certain ...
Speaking at BIO 2025, Makary bemoaned what he called “unnecessary steps” and “avoidable delays” in the U.S. regulatory ...
Vinay Prasad is taking on several big roles at the FDA, solidifying his position as a top adviser to Commissioner Marty ...
Vinay Prasad, the FDA’s freshly appointed head of vaccines, has been named chief medical and scientific officer, taking on ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results